This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Addgene
product type :
cDNA
product name :
6X-STAT-synthetic luciferase
catalog :
37392
citations: 2
| Reference |
|---|
Baeg G, Zhou R, Perrimon N. Genome-wide RNAi analysis of JAK/STAT signaling components in Drosophila. Genes Dev. 2005;19:1861-70 pubmed
|
product information
Catalog Number :
37392
Product Name :
6X-STAT-synthetic luciferase
article :
| doi | 10.1101/gad.1320705 |
| id | 5481 |
| pubmed_id | 16055650 |
bacterial resistance :
Ampicillin
cloning :
| backbone | pUAST | ||
| backbone_mutation | |||
| backbone_origin | |||
| backbone_size | 8904 | ||
| promoter | |||
| sequencing_primer_3 | |||
| sequencing_primer_5 | |||
| vector_types |
|
growth notes :
AACGGTTTCCCAGAACGCAGCGTATAAACGGTTTCCGCGAACGCAGCGTATAAACGGTTTCCCAGAATGCA and (2) GCTGCGTTCGCGGAAACCGTTTATACGCTGCGTTCTGGGAAACCGTTTATACGCTGCGTTCGCGGAA, AATTTTCCGCGAACGCAGCGTATAAACGGTTTCCCAGAACGCAGCGTATAAACGGTTTCCGCGAACGCAGCGTATA were annealed, respectively, and cloned together into pUAST. Subsequently, an XhoI/XbaI fragment containing the firefly luciferase gene from the pGL3 luciferase vector (Promega) and the hsp70 minimal promoter were subcloned into the resulting vector using XhoI/XbaI and NotI/XhoI sites, respectively, to generate the 6XSTAT synthetic-luc construct.
TTCTGGGAAACCGTTTATACGCTGCGTTCGCGGAAACCG
TTTATACGCTGCGTTCTGGGAAACCGTTTATAC,
Perrimon Lab plasmid #445 To generate a reporter construct containing six STAT consensus sites (TCCNNNGGA), two pairs of oligos (1)
TTCTGGGAAACCGTTTATACGCTGCGTTCGCGGAAACCG
TTTATACGCTGCGTTCTGGGAAACCGTTTATAC,
Perrimon Lab plasmid #445 To generate a reporter construct containing six STAT consensus sites (TCCNNNGGA), two pairs of oligos (1)
origin :
37
pi :
|
resistance markers :
| 1275 |
tags :
Unknown
company information
Addgene
490 Arsenal Way, Suite 100
Watertown, MA 02472
Watertown, MA 02472
info@addgene.org
https://www.addgene.org617.225.9000
headquarters: USA
questions and comments
